Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsReceivables Refunds
Ratios

OptimizeRx (OPRX) Depreciation & Amortization (IS): 2022-2025

Historic Depreciation & Amortization (IS) for OptimizeRx (OPRX) over the last 4 years, with Q3 2025 value amounting to $1.1 million.

  • OptimizeRx's Depreciation & Amortization (IS) fell 136.99% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 32.5%. This contributed to the annual value of $4.3 million for FY2024, which is 8022.48% up from last year.
  • OptimizeRx's Depreciation & Amortization (IS) amounted to $1.1 million in Q3 2025, which was down 136.99% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Depreciation & Amortization (IS) registered a high of $1.1 million during Q3 2024, and its lowest value of $456545.0 during Q4 2022.
  • For the 4-year period, OptimizeRx's Depreciation & Amortization (IS) averaged around $800135.3, with its median value being $1.0 million (2023).
  • Its Depreciation & Amortization (IS) has fluctuated over the past 5 years, first crashed by 1956.65% in 2023, then soared by 13447.54% in 2024.
  • Over the past 4 years, OptimizeRx's Depreciation & Amortization (IS) (Quarter) stood at $456545.0 in 2022, then surged by 120.57% to $1.0 million in 2023, then rose by 8.64% to $1.1 million in 2024, then decreased by 1.28% to $1.1 million in 2025.
  • Its Depreciation & Amortization (IS) stands at $1.1 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.1 million for Q1 2025.